
1. enferm infecc microbiol clin. 2019 mar;37(3):195-202. doi:
10.1016/j.eimc.2018.02.010. epub 2018 jun 18.

executive summary gesida/national aids plan consensus document on
antiretroviral therapy adults infected human immunodeficiency virus
(updated january 2018).

[article english, spanish]

aids study group (gesida) spanish society infectious diseases and
clinical microbiology national aids plan:.

collaborators: pérez-molina ja(1), polo r(2), lópez-aldeguer j(3), lozano f(4),
aguirrebengoa k(5), arribas jr(6), boix v(7), berenguer j(8), blanco jr(9),
domingo p(10), estrada v(11), galindo mj(12), garcía f(13), gatell jm(14),
gonzález-garcía j(6), gutiérrez f(15), iribarren ja(16), knobel h(17), llibre
jm(18), lópez-bernaldo de quirós jc(8), lópez-cortés lf(19), losa je(20), mariño 
a(21), miró jm(14), montes ml(6), moreno s(1), negredo e(18), pérez-elías mj(1), 
podzamczer d(22), portilla j(7), poveda e(23), pulido f(24), ribera e(25), rivero
a(26), rubio r(24), santos j(27), sanz-moreno j(28), sanz-sanz j(29), serrano
s(1), de la torre j(30), tuset m(31), von wichman ma(32), martínez e(31).

author information: 
(1)hospital ramón cajal - irycis, madrid, spain.
(2)secretaría del plan nacional sobre el sida, ministerio de sanidad, servicios
sociales e igualdad, madrid, spain.
(3)hospital universitario la fe - iislafe, valencia, spain.
(4)hospital universitario virgen de valme, sevilla, spain. electronic address:
fernandolozano@telefonica.net.
(5)hospital universitario cruces, bilbao, spain.
(6)hospital universitario la paz - idipaz, madrid, spain.
(7)hospital general universitario, alicante, spain.
(8)hospital general universitario gregorio marañón, madrid, spain.
(9)hospital san pedro - cibir, logroño, spain.
(10)hospitals universitaris arnau de vilanova santa maria, universitat de
lleida, irb-lleida, lleida, spain.
(11)hospital clínico san carlos, madrid, spain.
(12)hospital clínico universitario, valencia, spain.
(13)hospital universitario san cecilio, granada, spain.
(14)hospital clínic universitari - idibaps, ub, barcelona, spain.
(15)hospital general universitario de elche universidad miguel hernández de
alicante, spain.
(16)hospital universitario donostia, instituto biodonostia, san sebastián, spain.
(17)hospital del mar, barcelona, spain.
(18)hospital germans trías pujol, badalona, spain.
(19)hospital universitario virgen del rocío - ibis, sevilla, spain.
(20)hospital universitario fundación alcorcón, madrid, spain.
(21)complejo hospitalario universitario de ferrol, spain.
(22)idibell - hospital universitari de bellvitge, l'hospitalet, barcelona, spain.
(23)complejo hospitalario universitario - inibic, coruña, spain.
(24)hospital universitario 12 de octubre, madrid, spain.
(25)hospital universitari vall de hebron, barcelona, spain.
(26)hospital universitario reina sofía, córdoba, spain.
(27)hospital universitario virgen de la victoria - ibima, málaga, spain.
(28)hospital universitario príncipe de asturias, alcalá de henares, madrid,
spain.
(29)hospital universitario de la princesa, madrid, spain.
(30)hospital costa del sol, marbella, spain.
(31)hospital clinic universitari - idibaps, ub, barcelona, spain.
(32)hospital universitario donostia - instituto biodonostia, san sebastián,
spain.

this update document antiretroviral therapy (art) adults, 
been prepared jointly gesida spanish national aids plan last
two decades, supersedes document published 2017.1 update provides
physicians treating hiv-1-infected adults evidence-based recommendations 
guide therapeutic decisions. main difference respect the
previous document concerns recommended initial art regimens, three 
are maintained preferential. three include dolutegravir raltegravir,
together emtricitabine/tenofovir alafenamide abacavir/lamivudine. other
differences concern section switching art patients suppressed
viral replication, includes new two- three-drug regimens, the
antiretroviral drugs recommended pregnant women patients with
tuberculosis. recommendation also added patients present 
acute hiv infection pre-exposure prophylaxis.

copyright © 2018 elsevier españa, s.l.u. sociedad española de enfermedades
infecciosas microbiología clínica. rights reserved.

doi: 10.1016/j.eimc.2018.02.010 
pmid: 29759422  [indexed medline]

